Celebrex, Vioxx GI Safety Differences May Be Indistinguishable - FDA Cmte.

Gastrointestinal safety outcome differences between Pharmacia/Pfizer's Celebrex and Merck's Vioxx may be a factor of statistical "technicalities," FDA Arthritis Advisory Committee voting consultant David Wofsy, MD, University of California-San Francisco, suggested.

More from Archive

More from Pink Sheet